Methylphenidate and Oxygen saturation decreased - a phase IV clinical study of FDA data

Summary:

Oxygen saturation decreased is reported as a side effect among people who take Methylphenidate (methylphenidate), especially for people who are female, 10-19 old, have been taking the drug for 1 - 2 years also take Albuterol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Oxygen saturation decreased when taking Methylphenidate. It is created by eHealthMe based on reports of 8,120 people who have side effects when taking Methylphenidate from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,217 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Oxygen saturation decreased?

Oxygen saturation decreased is found to be associated with 1,849 drugs and 2,095 conditions by eHealthMe. Check the latest studies of Oxygen saturation decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

8,120 people reported to have side effects when taking Methylphenidate.
Among them, 19 people (0.23%) have Oxygen saturation decreased.

Could Methylphenidate cause Oxygen saturation decreased?

Among these 19 people:

How long have people been on Methylphenidate when they have Oxygen saturation decreased? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Oxygen saturation decreased when taking Methylphenidate? *

  • female: 63.16 %
  • male: 36.84 %

What is the age of people who have Oxygen saturation decreased when taking Methylphenidate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 27.78 %
  • 20-29: 22.22 %
  • 30-39: 16.67 %
  • 40-49: 11.11 %
  • 50-59: 11.11 %
  • 60+: 11.11 %

What are other drugs people take besides Methylphenidate? *

  1. Albuterol: 8 people, 42.11%
  2. Lansoprazole: 4 people, 21.05%
  3. Actemra: 4 people, 21.05%
  4. Acetaminophen: 3 people, 15.79%
  5. Nystatin: 3 people, 15.79%
  6. Cefazolin: 3 people, 15.79%
  7. Cefotaxime: 3 people, 15.79%
  8. Celebrex: 3 people, 15.79%
  9. Dexamethasone: 3 people, 15.79%
  10. Dimenhydrinate: 3 people, 15.79%

What are other side effects people have besides Oxygen saturation decreased? *

  1. Dyspnea (difficult or laboured breathing): 5 people, 26.32%
  2. Headache (pain in head): 5 people, 26.32%
  3. Weight Increased: 4 people, 21.05%
  4. Stress And Anxiety: 4 people, 21.05%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 21.05%
  6. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 21.05%
  7. Respiratory Distress (difficulty in breathing): 4 people, 21.05%
  8. Joint Pain: 3 people, 15.79%
  9. Cat Scratch Disease (bacterial infection by cat scratch): 3 people, 15.79%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 15.79%

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 21.05%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 21.05%
  3. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 3 people, 15.79%
  4. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 15.79%
  5. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 3 people, 15.79%
  6. Psychomotor Hyperactivity (feelings of extreme restlessness): 2 people, 10.53%
  7. Pneumonia: 2 people, 10.53%
  8. Otitis Media Acute (rapid inflammation of the middle ear): 2 people, 10.53%
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 2 people, 10.53%
  10. Chronic Respiratory Failure: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and have Oxygen saturation decreased?

- Check whether Oxygen saturation decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylphenidate:

Oxygen saturation decreased treatments and more:

How severe was Oxygen saturation decreased and when was it recovered:

Expand to all the drugs that have ingredients of methylphenidate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oxygen saturation decreased:

Browse all the conditions that are associated with Oxygen saturation decreased:


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate (the active ingredients of Methylphenidate) and Methylphenidate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: